Show items per page
Elements: 136
Page 1 on 7
 TitleAuthors / EditorsDate
add to browser selection
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease Hatterer, Eric; Shang, Limin; Simonet, Pierre; Herren, Suzanne; ... De Min, Cristina 2016
add to browser selection
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions Lombardi, Tommaso; Moll, Solange; Youinou, Pierre; Pers, Jacques-Olivier; ... Huard, Bertrand 2011
add to browser selection
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial Genevay, Stéphane; Finckh, Axel; Zufferey, P; Viatte, Sébastien; ... Gabay, Cem 2012
add to browser selection
Adalimumab in severe and acute sciatica: a multicenter, randomized, double-blind, placebo-controlled trial Genevay, Stéphane; Viatte, Sébastien; Finckh, Axel; Zufferey, Pascal; ... Gabay, Cem 2010
add to browser selection
Adaptive immune response in JAM-C-deficient mice: normal initiation but reduced IgG memory Zimmerli, Claudia; Lee, B. P.; Palmer, Gaby; Gabay, Cem; ... Imhof, Beat 2009
add to browser selection
Adipokines correlate with pain in lower limb osteoarthritis: different associations in hip and knee Bas, Sylvette; Finckh, Axel; Puskas, Gabor Janos; Suva, Domizio; ... Luebbeke-Wolff, Anne 2014
add to browser selection
Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure Announ, Nadia; Palmer, Gaby; Guerne, Pierre-André; Gabay, Cem 2009
add to browser selection
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis Vuilleumier, Nicolas; Bas, Sylvette; Pagano, Sabrina; Montecucco, Fabrizio; ... Gabay, Cem 2010
add to browser selection
Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice Lamacchia, Céline; Rodriguez, Emiliana; Palmer-Lourenco, Gaby; Vigne, Solenne; ... Gabay, Cem 2012
add to browser selection
At the horizon of innovative therapy in rheumatology: new biologic agents Finckh, Axel; Gabay, Cem 2008
add to browser selection
Atherosclerosis severity is not affected by a deficiency in IL-33/ST2 signaling Martin, Praxedis Sina; Palmer-Lourenco, Gaby; Rodriguez, Emiliana; Woldt, Estelle; ... Gabay, Cem 2015
add to browser selection
Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis Waldburger, Jean-Marc; Palmer-Lourenco, Gaby; Seemayer, Christian Alexander; Lamacchia, Céline; ... Gabay, Cem 2011
add to browser selection
Biological agents in monotherapy for the treatment of rheumatoid arthritis Gabay, Cem; Hasler, P; Kyburz, D; So, A; ... Walker, U 2014
add to browser selection
Biological agents in the management of adult-onset Still's disease Girard-Guyonvarc'h, Charlotte; Gabay, Cem 2018
add to browser selection
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement Schoels, Monika M; van der Heijde, Désirée; Breedveld, Ferdinand C; Burmester, Gerd R; ... Smolen, Josef S 2013
add to browser selection
Cardiovascular risk in patients with rheumatoid arthritis Lauper, Kim; Gabay, Cem 2017
add to browser selection
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies Bandelier, Cédric; Guerne, Pierre-André; Genevay, Stéphane; Finckh, Axel; Gabay, Cem 2009
add to browser selection
Coexistence of seropositive rheumatoid arthritis and SAPHO syndrome Nissen, Michael John; Syrogiannopoulou, Aphrodite; Gabay, Cem 2013
add to browser selection
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration Lauper, Kim; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; ... Gabay, Cem 2018
add to browser selection
Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis Du Pan, Sophie Martin; Dehler, Silvia; Ciurea, Adrian; Ziswiler, Hans-Rudolf; ... Finckh, Axel 2009
<< previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 |